As more states consider adding the American Dental Association’s “oral preventive assistant,” dental hygienists assert patient care will suffer and suggest moving the profession toward self-governance.
Read More...
When a Bargain Smile Comes at a High Cost
With millions of Americans traveling abroad for cheaper dental care, a tragic case in Turkey underscores the potentially serious…
Is Povidone-Iodine the Underrated Antiseptic in Dentistry?
With broad antimicrobial activity, low cost and multiple potential oral health applications, povidone-iodine may be a valuable…
Can Your Patients Hear You?
With hearing loss affecting more than 50 million Americans, oral health professionals can improve communication, reduce anxiety and…
AI May Make Chairside Diagnosis of Cognitive Impairment a Reality
New research suggests AI can analyze subtle changes in speech during routine patient-provider interactions to identify early signs…
Weekly Popular
Personal Finance
More Top Stories
Research Provides Key Insight Into Severe COVID-19 Illness
While advanced age and comorbidities are well-known risk factors for severe illness caused by COVID-19, it was still not understood why some people became gravely ill, whereas other patients of similar backgrounds recovered quickly.…
Can a New Drug Formulation Treat Candida Infections
Candida albicans infections in the mouth are often painful for people who develop infections such as burning mouth syndrome or thrush.
Pfizer Is Confident About Distribution of Its COVID-19 Vaccine
United States pharmaceutical giant, Pfizer, whose two-shot COVID-19 vaccine recently showed 90% effectiveness in preliminary studies, is ready to roll out millions of doses as soon as it receives approval from the US Food and Drug…
Does COVID-19 Increase Risk for Mental Illness?
A new study found that patients who recovered from COVID-19 were at elevated risk for mental illness. Published in the British medical journal The Lancet, results demonstrated that one in five patients who had recovered from a SARS-CoV-2…
FDA Provides EUA for COVID-19 Treatment
On November 9, the United States Food and Drug Administration issued an emergency use authorization (EUA) to bamlanivimab for the treatment of mild-to-moderate COVID-19. The monoclonal antibody therapy is authorized for COVID-19 patients…
Pfizer Takes the Lead in the Race to Develop a COVID-19 Vaccine
The American pharmaceutical company Pfizer reported that its COVID-19 vaccine is highly effective in preventing infection with the novel coronavirus in preliminary studies. In light of rising case numbers across the United States, this is…
Sunstar Americas, Inc. Issues Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral…
Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 6/30/22 – 9/30/22 (see specific lots below) to the consumer level. This product may be…
Mutated Strain of Coronavirus Found in Danish Mink Population
A mutated version of the coronavirus has infected the farmed mink population in Denmark, the largest supplier of mink fur in the world. Thus far, the mutation has impacted more than 200 mink farms and over 200 Danes have been infected with…
Can a Nasal Spray Prevent COVID-19?
Columbia University researchers have developed a nasal spray designed to prevent infection with the novel coronavirus, and an initial study conducted on ferrets demonstrates efficacy. While the study was small and has not undergone peer…
FDA Takes Action Against Manufacturers of Products Making False COVID-19 Claims
The United States Food and Drug Administration (FDA) asked two companies to stop selling products due to false claims made about their ability to prevent and/or treat the illness associated with the novel coronavirus. The requests were…
Market Media
- Advertisement -
